Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taurolite for prevention of recurrent common bile duct stones after endoscopic stone clearance
ChiCTR1900020800Phase 4Not yet recruiting
- Sponsor
- Lanzhou Second People's Hospital
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in choledocholithiasis comparing Taurolite with Placebo (2 arms). Primary endpoints: Common bile duct stones recurrence and Blood routine. Planned start Jan 2019; status: not yet recruiting.
02
Drugs
tauroursodeoxycholic acid
03
Conditions
choledocholithiasis
Beyond the preview
Go deeper on ChiCTR1900020800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900020800.